Patents by Inventor Peter Lelkes

Peter Lelkes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120058090
    Abstract: The invention provides engineered biomaterials derived from plant products. The engineered biomaterials are useful for biomedical applications. The engineered biomaterials are able to support the growth of animal cells.
    Type: Application
    Filed: February 14, 2008
    Publication date: March 8, 2012
    Inventor: Peter Lelkes
  • Publication number: 20100034791
    Abstract: The present invention relates to compositions comprising fetal pulmonary cells and biocompatible materials. The present invention also provides an engineered three dimensional lung tissue exhibiting characteristics of a natural lung tissue. The engineered tissue is useful for the study of lung developmental biology and pathology as well as drug discovery.
    Type: Application
    Filed: February 14, 2008
    Publication date: February 11, 2010
    Inventors: Peter Lelkes, Christine M. Pinck, Mark J. Mondrinos
  • Publication number: 20060263417
    Abstract: Non-woven fibrous scaffolds made by electrospinning from the synthetic biodegradable polymer such as, for example, poly(lactic-co-glycolic acid) (PLGA) and natural proteins, such as, for example, gelatin (denatured collagen) and elastin and a method of making thereof.
    Type: Application
    Filed: May 10, 2006
    Publication date: November 23, 2006
    Inventors: Peter Lelkes, Mengyan Li, Mark Mondrinos, Frank Ko
  • Publication number: 20060223125
    Abstract: Methods and kits are provided for staining cell membranes using a biotinylated phospholipid in conjunction with streptavidin-coated quantum dots.
    Type: Application
    Filed: December 1, 2005
    Publication date: October 5, 2006
    Inventors: Peter Lelkes, Bahar Edrissi, Elisabeth Papazoglou
  • Patent number: 4670394
    Abstract: The present invention discloses a new line of endothelial cell of adrenal medullary origin capable of producing blood clotting Factor VIII:C. A method of isolating and culturing said cell line has also been disclosed. Factor VIII:C is useful in treating hemophilia.
    Type: Grant
    Filed: November 16, 1984
    Date of Patent: June 2, 1987
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Harvey B. Pollard, Richard Ornberg, Dipak Banerjee, Moussa Youdim, Peter Lelkes, Eli Heldman